NO952579D0 - Tiacykloalkyl-indolforbindelser, fremgangsmåte ved deres fremstilling, samt farmasöytiske preparater inneholdende dem - Google Patents

Tiacykloalkyl-indolforbindelser, fremgangsmåte ved deres fremstilling, samt farmasöytiske preparater inneholdende dem

Info

Publication number
NO952579D0
NO952579D0 NO952579A NO952579A NO952579D0 NO 952579 D0 NO952579 D0 NO 952579D0 NO 952579 A NO952579 A NO 952579A NO 952579 A NO952579 A NO 952579A NO 952579 D0 NO952579 D0 NO 952579D0
Authority
NO
Norway
Prior art keywords
alkyl
thiacycloalkyl
preparation
alkoxy
pharmaceutical preparations
Prior art date
Application number
NO952579A
Other languages
English (en)
Other versions
NO305022B1 (no
NO952579L (no
Inventor
Paul Caubere
Brigitte Jamart-Gregoire
Catherine Caubere
Dominique Manechez
Pierre Renard
Gerard Adam
Catherine Nguyen
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO952579D0 publication Critical patent/NO952579D0/no
Publication of NO952579L publication Critical patent/NO952579L/no
Publication of NO305022B1 publication Critical patent/NO305022B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO952579A 1994-06-28 1995-06-27 Tiacykloalkylindolforbindelser og farmas°ytiske preparater inneholdende dem NO305022B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9407888A FR2721610B1 (fr) 1994-06-28 1994-06-28 Nouveaux dérivés (thia)cycloalkyl [b] indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (3)

Publication Number Publication Date
NO952579D0 true NO952579D0 (no) 1995-06-27
NO952579L NO952579L (no) 1995-12-29
NO305022B1 NO305022B1 (no) 1999-03-22

Family

ID=9464699

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952579A NO305022B1 (no) 1994-06-28 1995-06-27 Tiacykloalkylindolforbindelser og farmas°ytiske preparater inneholdende dem

Country Status (16)

Country Link
US (1) US5635516A (no)
EP (1) EP0690050B1 (no)
JP (1) JP3004566B2 (no)
CN (1) CN1054374C (no)
AT (1) ATE186722T1 (no)
AU (1) AU686800B2 (no)
CA (1) CA2152725A1 (no)
DE (1) DE69513332T2 (no)
DK (1) DK0690050T3 (no)
ES (1) ES2141904T3 (no)
FI (1) FI953193A (no)
FR (1) FR2721610B1 (no)
GR (1) GR3032172T3 (no)
NO (1) NO305022B1 (no)
NZ (1) NZ272447A (no)
ZA (1) ZA955355B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US20070225285A1 (en) * 2005-11-04 2007-09-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20070219206A1 (en) * 2005-11-04 2007-09-20 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US20070244128A1 (en) * 2005-11-04 2007-10-18 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7925075B2 (en) * 2007-05-07 2011-04-12 General Electric Company Inspection system and methods with autocompensation for edge break gauging orientation
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
KR20160129109A (ko) * 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2018129205A1 (en) * 2017-01-04 2018-07-12 The Trustees Of Dartmouth College Methods of inhibiting pcsk9
CN108558905B (zh) * 2018-05-21 2021-03-12 华南农业大学 一种噻喃[4,3-b]吲哚类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2243574A1 (de) * 1972-09-05 1974-03-14 Boehringer Mannheim Gmbh Aryloxy-essigsaeure-derivate und verfahren zur herstellung derselben
GB1432649A (no) * 1973-09-07 1976-04-22 Ici Ltd
CA1326030C (en) * 1987-07-21 1994-01-11 John W. Gillard Cyclohept[b]indolealkanoic acids
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
AU3128693A (en) * 1991-11-18 1993-06-15 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
US5314900A (en) * 1992-11-19 1994-05-24 Merck Frosst Canada, Inc. Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU686800B2 (en) 1998-02-12
FR2721610A1 (fr) 1995-12-29
FR2721610B1 (fr) 1996-08-23
NO305022B1 (no) 1999-03-22
CA2152725A1 (fr) 1995-12-29
NO952579L (no) 1995-12-29
ES2141904T3 (es) 2000-04-01
GR3032172T3 (en) 2000-04-27
CN1054374C (zh) 2000-07-12
US5635516A (en) 1997-06-03
FI953193A0 (fi) 1995-06-28
DE69513332D1 (de) 1999-12-23
NZ272447A (en) 1996-02-27
EP0690050A1 (fr) 1996-01-03
ZA955355B (en) 1996-02-12
ATE186722T1 (de) 1999-12-15
AU2327495A (en) 1996-01-11
DE69513332T2 (de) 2000-07-27
EP0690050B1 (fr) 1999-11-17
FI953193A (fi) 1995-12-29
JPH0812649A (ja) 1996-01-16
DK0690050T3 (da) 2000-04-17
CN1114957A (zh) 1996-01-17
JP3004566B2 (ja) 2000-01-31

Similar Documents

Publication Publication Date Title
NO952579D0 (no) Tiacykloalkyl-indolforbindelser, fremgangsmåte ved deres fremstilling, samt farmasöytiske preparater inneholdende dem
AU645867B2 (en) 2-arylthiazole derivative and pharmaceutical composition containing the same
ATE102920T1 (de) Serotonin- und norepinephrin-aufnahmeinhibitoren.
NO943876D0 (no) Behandling av peri-menopausalt syndrom
IE873449L (en) 3-aryloxypropanamine derivatives
CA2243199A1 (en) Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
NO179944C (no) Analogifremgangsmåte for fremstilling av N-fenylalkyl-substituerte <alfa>-aminokarboksamidderivater
UA27883C2 (uk) Засіб для інгібування небажаного відкладання фіброїдних тканин на стінці матки
AU640852B2 (en) N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
ES2132135T3 (es) Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura.
RU99101864A (ru) Новое производное тиофена и содержащая его фармацевтическая композиция
NO793354L (no) Derivater av polyen macrolid antibiotika inneholdende en aminosukkerdel, og fremgangsmaate ved fremstilling av disse
DE3868794D1 (de) Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO930452D0 (no) Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol
JPS6413086A (en) Pyrazole oxime derivative and germicide insecticide and acaricide containing said compound
ATE121394T1 (de) Konjugierte gamma-hydroxybutenolid-derivate und sie als aktiver wirkstoff enthaltende mittel gegen magengeschwüre.
EP0073454A3 (en) 6-alpha-methoxy-penicillins, their salts, process for their preparation and therapeutic agents containing these compounds
RU93058309A (ru) Производные тиазолидина, способ их получения, фармацевтическая композиция
NO960116L (no) Fremgangsmåte for fremstilling av en fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid
KR830000249A (ko) 세파로스포린 화합물의 제조방법
KR890002204A (ko) 신규의 디포스폰산 화합물 및 이들을 함유하는 제약 조성물

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000